Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 20;13(3):183.
doi: 10.3390/pathogens13030183.

Population Immunity and Polio Eradication

Affiliations
Review

Population Immunity and Polio Eradication

Paul E M Fine. Pathogens. .

Abstract

The Global Polio Eradication Initiative made immense progress after its establishment in 1988 as a consequence of high coverage with various poliovirus vaccines in all populations of the world. Problems have arisen in recent years, however, related to security issues in some countries, to the circulation of vaccine-derived polioviruses, and to the recognition that individuals with certain immune deficiencies can remain infected and infectious for many months or years. As natural infection and different vaccines have different effects on the immune system, the patterns of humoral and mucosal immunity to polioviruses in the world today are complex but are crucial to the ultimate success of the eradication initiative. This paper describes the background of the current situation and current immunological patterns and discusses their implications for managing population immunity to polioviruses in the years ahead.

Keywords: Polio; eradication; herd immunity; immunity; vaccination.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

Figure 1
Figure 1
Estimates of the basic reproduction numbers and simple theoretical “herd immunity thresholds” (calculated as: 1 − 1/R0) for wild poliovirus, in different populations, from References [4,5].

Similar articles

Cited by

References

    1. Musgrove P. Is polio eradication in the Americas economically justified? Bull. Pan Am. Health Organ. 1988;22:1–16. - PubMed
    1. Bart K., Foulds J., Patriarca P. Global eradication of poliomyelitis: Benefit-cost analysis. Bull. World Health Organ. 1996;74:35–45. - PMC - PubMed
    1. Fine P.E.M., Mulholland K., Scott J.A., Edmunds W.J. Community Protection. In: Orenstein W.A., Offit P.A., Edwards K.M., Plotkin S.A., editors. Vaccines. 8th ed. Elsevier Inc.; Philadelphia PA, USA: 2024. pp. 1063–1624. Chapter 78.
    1. Patriarca P.A., Sutter R.W., Oostvogel P.M. Outbreaks of paralytic poliomyelitis, 1976–1995. J. Infect. Dis. 1997;175((Suppl. 1)):S165–S172. doi: 10.1093/infdis/175.Supplement_1.S165. - DOI - PubMed
    1. Estivariz C.F., Burns C.C., Macklin G.R. Poliovirus vaccine–Live. In: Orenstein W.A., Offit P.A., Edwards K.M., Plotkin S.A., editors. Plotkin’s Vaccines. 8th ed. Elsevier Publishers; Philadelphia, PA, USA: 2024. Chapter 50.

Grants and funding

This research received no external funding.